ARCHIVES

DCCP Board Okays Concepts For Severn Contract Recompetitions, Denies Two Other

This article is from The Cancer Letter archive.

Vol. 07 No. 25 | June 19, 1981

Download PDF Visit The Full Archive

Related Articles

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

September 11, 1998

Research Opportunities In Pancreas Cancer Described; Top Priority Set

December 21, 1973

New Treatment Approaches Valuable For Cancer Pain, Quality Of Life

September 27, 2002

Britol-Meyers Holds Taxol Briefings, Outlines Timetable

July 5, 1991

In Surgery vs Radiotherapy, Outcome Differences Equalize After 15 Years Follow-up

February 22, 2013

In Brief: Unsolicited Proposals ‘Very Valuable,” DeVita Says, Asks Investigators To Keep Channel Open

April 18, 1975